{"id":"https://openalex.org/W7224990609","doi":"https://doi.org/10.1080/10406638.2026.2752861","title":"Synthesis, Characterization, Antiproliferative Potential and Molecular Docking Studies of Novel Phenyl Sulfonyl Clubbed Benzothiazolyl Piperidine-3-Carboxamides","display_name":"Synthesis, Characterization, Antiproliferative Potential and Molecular Docking Studies of Novel Phenyl Sulfonyl Clubbed Benzothiazolyl Piperidine-3-Carboxamides","publication_year":2026,"publication_date":"2026-10-31","ids":{"openalex":"https://openalex.org/W7224990609","doi":"https://doi.org/10.1080/10406638.2026.2752861"},"language":"en","primary_location":{"id":"doi:10.1080/10406638.2026.2752861","doi":"https://doi.org/10.1080/10406638.2026.2752861","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10406638.2026.2752861","pdf_url":null,"source":{"id":"https://openalex.org/S178924077","display_name":"Polycyclic aromatic compounds","issn_l":"1026-7743","issn":["1026-7743","1040-6638","1563-5333"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Polycyclic Aromatic Compounds","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084356121","display_name":"Obaid Afzal","orcid":"https://orcid.org/0000-0002-4188-5592","observed_orcids":["https://orcid.org/0000-0002-4188-5592"]},"institutions":[{"id":"https://openalex.org/I142608572","display_name":"Prince Sattam Bin Abdulaziz University","ror":"https://ror.org/04jt46d36","country_code":"SA","type":"education","lineage":["https://openalex.org/I142608572"]}],"countries":["SA"],"is_corresponding":true,"raw_author_name":"Obaid Afzal","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University"],"raw_orcid":"https://orcid.org/0000-0002-4188-5592","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University","institution_ids":["https://openalex.org/I142608572"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038085552","display_name":"Ali Altharawi","orcid":"https://orcid.org/0000-0002-6491-6611","observed_orcids":["https://orcid.org/0000-0002-6491-6611","https://orcid.org/0009-0008-2849-0933"]},"institutions":[{"id":"https://openalex.org/I142608572","display_name":"Prince Sattam Bin Abdulaziz University","ror":"https://ror.org/04jt46d36","country_code":"SA","type":"education","lineage":["https://openalex.org/I142608572"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Ali Altharawi","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University","institution_ids":["https://openalex.org/I142608572"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073777087","display_name":"Safar M. Alqahtani","orcid":"https://orcid.org/0000-0002-4140-7320","observed_orcids":["https://orcid.org/0000-0002-4140-7320"]},"institutions":[{"id":"https://openalex.org/I142608572","display_name":"Prince Sattam Bin Abdulaziz University","ror":"https://ror.org/04jt46d36","country_code":"SA","type":"education","lineage":["https://openalex.org/I142608572"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Safar M. Alqahtani","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University","institution_ids":["https://openalex.org/I142608572"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045606770","display_name":"Manal Abdullah Alossaimi","orcid":"https://orcid.org/0000-0001-8911-8109","observed_orcids":["https://orcid.org/0000-0001-8911-8109"]},"institutions":[{"id":"https://openalex.org/I142608572","display_name":"Prince Sattam Bin Abdulaziz University","ror":"https://ror.org/04jt46d36","country_code":"SA","type":"education","lineage":["https://openalex.org/I142608572"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Manal A. Alossaimi","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University","institution_ids":["https://openalex.org/I142608572"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034270431","display_name":"Taibah Aldakhil","orcid":"https://orcid.org/0009-0002-7822-3477","observed_orcids":["https://orcid.org/0009-0002-7822-3477"]},"institutions":[{"id":"https://openalex.org/I142608572","display_name":"Prince Sattam Bin Abdulaziz University","ror":"https://ror.org/04jt46d36","country_code":"SA","type":"education","lineage":["https://openalex.org/I142608572"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Taibah Aldakhil","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University","institution_ids":["https://openalex.org/I142608572"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158967035","display_name":"Alhumaidi Alabbas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142608572","display_name":"Prince Sattam Bin Abdulaziz University","ror":"https://ror.org/04jt46d36","country_code":"SA","type":"education","lineage":["https://openalex.org/I142608572"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Alhumaidi Alabbas","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University","institution_ids":["https://openalex.org/I142608572"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043561472","display_name":"Mubarak A. Alamri","orcid":"https://orcid.org/0000-0003-0678-593X","observed_orcids":["https://orcid.org/0000-0003-0678-593X"]},"institutions":[{"id":"https://openalex.org/I142608572","display_name":"Prince Sattam Bin Abdulaziz University","ror":"https://ror.org/04jt46d36","country_code":"SA","type":"education","lineage":["https://openalex.org/I142608572"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Mubarak A. Alamri","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University","institution_ids":["https://openalex.org/I142608572"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062607829","display_name":"Abdulmalik Saleh Alfawaz Altamimi","orcid":"https://orcid.org/0009-0002-8523-9039","observed_orcids":["https://orcid.org/0009-0002-8523-9039"]},"institutions":[{"id":"https://openalex.org/I142608572","display_name":"Prince Sattam Bin Abdulaziz University","ror":"https://ror.org/04jt46d36","country_code":"SA","type":"education","lineage":["https://openalex.org/I142608572"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Abdulmalik S.A. Altamimi","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University","institution_ids":["https://openalex.org/I142608572"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5084356121"],"corresponding_institution_ids":["https://openalex.org/I142608572"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.72495026,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1","last_page":"24"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13454","display_name":"Phenothiazines and Benzothiazines Synthesis and Activities","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benzothiazole-derivatives","display_name":"benzothiazole derivatives","score":0.9390000104904175},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.8629999756813049},{"id":"https://openalex.org/keywords/anticancer-drug-discovery","display_name":"anticancer drug discovery","score":0.6909999847412109},{"id":"https://openalex.org/keywords/sns-032","display_name":"SNS-032","score":0.8489999771118164},{"id":"https://openalex.org/keywords/cyclin-dependent-kinase-inhibitors","display_name":"cyclin-dependent kinase inhibitors","score":0.8050000071525574},{"id":"https://openalex.org/keywords/vegfr-2-inhibitors","display_name":"VEGFR-2 inhibitors","score":0.9739999771118164},{"id":"https://openalex.org/keywords/leukemia-cell-lines","display_name":"leukemia cell lines","score":0.8980000019073486},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9610000252723694},{"id":"https://openalex.org/keywords/kidney-cancer","display_name":"kidney cancer","score":0.7400000095367432},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.8980000019073486},{"id":"https://openalex.org/keywords/mtor","display_name":"mTOR","score":0.9869999885559082},{"id":"https://openalex.org/keywords/admet-prediction","display_name":"ADMET prediction","score":0.8539999723434448},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.8259999752044678},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9217000007629395},{"id":"https://openalex.org/C2777456753","wikidata":"https://www.wikidata.org/wiki/Q419096","display_name":"Benzothiazole","level":2,"score":0.8912000060081482},{"id":"https://openalex.org/C2776074239","wikidata":"https://www.wikidata.org/wiki/Q2452042","display_name":"Sulforhodamine B","level":4,"score":0.6312000155448914},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5230000019073486},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.48969998955726624},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4713999927043915},{"id":"https://openalex.org/C2994372470","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell lines","level":4,"score":0.44359999895095825},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.4108000099658966},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.40959998965263367},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4000000059604645},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.38929998874664307},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37630000710487366},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.37599998712539673},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.36469998955726624},{"id":"https://openalex.org/C126189478","wikidata":"https://www.wikidata.org/wiki/Q1468324","display_name":"Nephrotoxicity","level":3,"score":0.3452000021934509},{"id":"https://openalex.org/C87906975","wikidata":"https://www.wikidata.org/wiki/Q899114","display_name":"Sulfonyl","level":3,"score":0.3447999954223633},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.335099995136261},{"id":"https://openalex.org/C2778464347","wikidata":"https://www.wikidata.org/wiki/Q413426","display_name":"Thiazole","level":2,"score":0.3222000002861023},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.3122999966144562},{"id":"https://openalex.org/C2777162773","wikidata":"https://www.wikidata.org/wiki/Q2013529","display_name":"Quinazolinone","level":2,"score":0.3068999946117401},{"id":"https://openalex.org/C3018146709","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Anticancer drug","level":3,"score":0.3052000105381012},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.29649999737739563},{"id":"https://openalex.org/C2778818824","wikidata":"https://www.wikidata.org/wiki/Q193430","display_name":"Heterocyclic compound","level":2,"score":0.2854999899864197},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.28519999980926514},{"id":"https://openalex.org/C69366308","wikidata":"https://www.wikidata.org/wiki/Q2272286","display_name":"ADME","level":3,"score":0.26969999074935913},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.26159998774528503},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2590000033378601},{"id":"https://openalex.org/C2778115740","wikidata":"https://www.wikidata.org/wiki/Q1215575","display_name":"Naproxen","level":3,"score":0.2556999921798706},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.25440001487731934},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.2531999945640564}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1080/10406638.2026.2752861","doi":"https://doi.org/10.1080/10406638.2026.2752861","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10406638.2026.2752861","pdf_url":null,"source":{"id":"https://openalex.org/S178924077","display_name":"Polycyclic aromatic compounds","issn_l":"1026-7743","issn":["1026-7743","1040-6638","1563-5333"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Polycyclic Aromatic Compounds","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311227","display_name":"Prince Sattam bin Abdulaziz University","ror":"https://ror.org/04jt46d36"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":64,"referenced_works":["https://openalex.org/W1956545442","https://openalex.org/W1990524359","https://openalex.org/W1991998089","https://openalex.org/W2011568285","https://openalex.org/W2027996680","https://openalex.org/W2063544208","https://openalex.org/W2066417528","https://openalex.org/W2070643112","https://openalex.org/W2075209098","https://openalex.org/W2081467800","https://openalex.org/W2087312216","https://openalex.org/W2092204388","https://openalex.org/W2095492902","https://openalex.org/W2098748257","https://openalex.org/W2101635775","https://openalex.org/W2102377211","https://openalex.org/W2124662474","https://openalex.org/W2129868701","https://openalex.org/W2133051701","https://openalex.org/W2156373035","https://openalex.org/W2168180694","https://openalex.org/W2402872745","https://openalex.org/W2433699578","https://openalex.org/W2802174459","https://openalex.org/W2900960361","https://openalex.org/W2955852147","https://openalex.org/W2992038112","https://openalex.org/W2995167300","https://openalex.org/W3080704572","https://openalex.org/W3087047342","https://openalex.org/W3136135933","https://openalex.org/W3137945226","https://openalex.org/W3203420675","https://openalex.org/W4223637031","https://openalex.org/W4284992638","https://openalex.org/W4307906310","https://openalex.org/W4310788330","https://openalex.org/W4387452990","https://openalex.org/W4390747020","https://openalex.org/W4390766501","https://openalex.org/W4392345883","https://openalex.org/W4393935425","https://openalex.org/W4395010444","https://openalex.org/W4396633092","https://openalex.org/W4399242663","https://openalex.org/W4399940463","https://openalex.org/W4401220606","https://openalex.org/W4402528165","https://openalex.org/W4404302852","https://openalex.org/W4404330854","https://openalex.org/W4405315657","https://openalex.org/W4406186402","https://openalex.org/W4408095952","https://openalex.org/W4409781029","https://openalex.org/W4410176921","https://openalex.org/W4410888816","https://openalex.org/W4412917981","https://openalex.org/W4415427092","https://openalex.org/W4415621876","https://openalex.org/W4417164794","https://openalex.org/W4417432963","https://openalex.org/W7128770477","https://openalex.org/W7163913569","https://openalex.org/W7165615203"],"related_works":["https://openalex.org/W7133817678","https://openalex.org/W2903302890","https://openalex.org/W7154583806","https://openalex.org/W2468810145","https://openalex.org/W7116289679","https://openalex.org/W4413999993","https://openalex.org/W4291788844","https://openalex.org/W3009684268","https://openalex.org/W4402417995","https://openalex.org/W7096793953"],"abstract_inverted_index":{"Global":[0],"cancer":[1,99,145,150],"incidence":[2],"has":[3],"approached":[4],"nearly":[5],"21":[6],"million":[7,18],"new":[8,19],"cases":[9],"annually":[10],"and":[11,44,53,67,82,139,148,173,198],"predicted":[12,179],"to":[13,16,162,167,188],"exceed":[14],"34":[15],"35":[17],"annual":[20],"diagnoses":[21],"by":[22,37,104],"2050.":[23],"Benzothiazole":[24],"is":[25],"a":[26,79,95],"vital":[27],"privileged":[28],"heterocyclic":[29],"scaffold":[30],"in":[31,165,191],"anticancer":[32,175],"drug":[33,176],"discovery,":[34],"as":[35],"evident":[36],"Quizartinib":[38],"(FDA-approved":[39],"for":[40,90,200],"acute":[41],"myeloid":[42],"leukemia)":[43],"Phortress":[45],"(successful":[46],"Phase":[47],"I":[48],"clinical":[49],"trials":[50],"against":[51,130,171],"breast":[52],"ovarian":[54],"cancers).":[55],"In":[56,154],"the":[57,71,122,168,184],"present":[58],"study,":[59],"some":[60],"novel":[61],"benzothiazole":[62],"derivatives":[63],"8(A-J)":[64],"were":[65,88],"designed":[66],"synthesized,":[68],"based":[69],"on":[70,94],"promising":[72],"results":[73],"obtained":[74],"after":[75],"structural":[76],"modification":[77],"of":[78,97,133,182,193],"multitargeted":[80],"CDKs":[81],"VEGFR2":[83],"inhibitor,":[84],"SNS-032.":[85],"The":[86,178],"compounds":[87,123,185],"investigated":[89],"their":[91],"antiproliferative":[92,118],"potential":[93],"total":[96],"60":[98],"cell":[100,131,143],"lines":[101,132],"(NCI,":[102],"USA)":[103],"sulforhodamine":[105],"B":[106],"(SRB)":[107],"assay":[108],"at":[109],"10":[110],"\u00b5M":[111],"concentration.":[112],"Compound":[113],"8":[114,158,201],"A":[115,159],"exhibited":[116],"good":[117,125],"activity":[119],"among":[120],"all":[121,183],"with":[124],"%":[126],"growth":[127],"inhibition":[128],"(%GI)":[129],"leukemia":[134],"(SR,":[135],"82.73%;":[136],"K-562,":[137],"73.48%;":[138],"MOLT-4,":[140],"70.32%),":[141],"non-small":[142],"lung":[144],"(HOP-92,":[146],"93.42%),":[147],"renal":[149],"(RXF":[151],"393,":[152],"85.12%).":[153],"molecular":[155],"docking":[156],"studies,":[157],"was":[160,186],"found":[161,187],"be":[163,189],"active":[164],"comparison":[166],"co-crystallized":[169],"ligands":[170],"BCL-2":[172],"mTOR":[174],"targets.":[177],"ADMET":[180],"profile":[181],"favorable":[190],"terms":[192],"toxicity,":[194],"except":[195],"slight":[196],"hepatotoxicity":[197],"nephrotoxicity":[199],"A.":[202]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-11-01T00:00:00"}